Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex
- PMID: 18023148
- DOI: 10.1016/j.eplepsyres.2007.10.002
Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex
Abstract
Cortical tubers and subependymal giant cell tumors (SGCT) are two major cerebral lesions associated with tuberous sclerosis complex (TSC). In the present study, we investigated immunocytochemically the inflammatory cell components and the induction of two major pro-inflammatory pathways (the interleukin (IL)-1beta and complement pathways) in tubers and SGCT resected from TSC patients. All lesions were characterized by the prominent presence of microglial cells expressing class II-antigens (HLA-DR) and, to a lesser extent, the presence of CD68-positive macrophages. We also observed perivascular and parenchymal T lymphocytes (CD3(+)) with a predominance of CD8(+) T-cytotoxic/suppressor lymphoid cells. Activated microglia and reactive astrocytes expressed IL-1beta and its signaling receptor IL-1RI, as well as components of the complement cascade, such as C1q, C3c and C3d. Albumin extravasation, with uptake in astrocytes, was observed in both tubers and SGCT, suggesting that alterations in blood brain barrier permeability are associated with inflammation in TSC-associated lesions. Our findings demonstrate a persistent and complex activation of inflammatory pathways in cortical tubers and SGCT.
Similar articles
-
Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.Neuroscience. 2008 Sep 22;156(1):203-15. doi: 10.1016/j.neuroscience.2008.06.073. Epub 2008 Jul 25. Neuroscience. 2008. PMID: 18706978
-
Tuberous sclerosis: a primary pathology of astrocytes?Epilepsia. 2008;49 Suppl 2:53-62. doi: 10.1111/j.1528-1167.2008.01493.x. Epilepsia. 2008. PMID: 18226172
-
Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex.Neurology. 2009 Mar 31;72(13):1165-9. doi: 10.1212/01.wnl.0000345365.92821.86. Neurology. 2009. PMID: 19332694
-
Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.Congenit Anom (Kyoto). 2007 Mar;47(1):2-8. doi: 10.1111/j.1741-4520.2006.00134.x. Congenit Anom (Kyoto). 2007. PMID: 17300684 Review.
-
Tuberous sclerosis and epilepsy: role of astrocytes.Glia. 2012 Aug;60(8):1244-50. doi: 10.1002/glia.22326. Epub 2012 Mar 21. Glia. 2012. PMID: 22438024 Review.
Cited by
-
Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus.Neurosurg Focus. 2013 Jun;34(6):E5. doi: 10.3171/2013.3.FOCUS1336. Neurosurg Focus. 2013. PMID: 23724839 Free PMC article.
-
Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model.Genome Med. 2016 Sep 21;8(1):94. doi: 10.1186/s13073-016-0347-3. Genome Med. 2016. PMID: 27655340 Free PMC article.
-
Tsc2 mutation rather than Tsc1 mutation dominantly causes a social deficit in a mouse model of tuberous sclerosis complex.Hum Genomics. 2023 Feb 2;17(1):4. doi: 10.1186/s40246-023-00450-2. Hum Genomics. 2023. PMID: 36732866 Free PMC article.
-
n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis.Brain. 2018 Nov 1;141(11):3130-3143. doi: 10.1093/brain/awy247. Brain. 2018. PMID: 30307467 Free PMC article.
-
α-methyl-L-tryptophan: mechanisms for tracer localization of epileptogenic brain regions.Biomark Med. 2011 Oct;5(5):567-75. doi: 10.2217/bmm.11.73. Biomark Med. 2011. PMID: 22003905 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous